ASTCT 2022 CAR T Webinar Series

This webinar series debuted in August 2022, highlighting several topics and cutting edge research in the field of CAR T. Recordings and slides from the live webinars have been posted here for your easy viewing.

Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.

  • Contains 2 Component(s)

    The ASTCT webinar, 'CAR T Manufacturing,' aired on August 25, 2022 at 1 PM CDT.

    After the success of the 2021 CAR T Webinar Series, ASTCT is excited to announce another six-part CAR T Webinar Series sponsored by Janssen and Legend Biotech for 2022!

    In this hour-long webinar, Dr. Megan Davis, Dr. Andrew Timmons, and Dr. Boro Dropulić discussed aspects of local manufacturing, an overview of navigating regulation in gene and cell therapy, and the place-of-care manufacturing of CAR-T cells. After their presentations, Drs. Davis and Timmons answered audience questions. 

    Moderator:

    Dr. Armin Ghobadi; Associate Professor of Medicine, Division of Medical Oncology, Washington University School of Medicine

    Faculty:

    Dr. Megan (Suhoski) Davis; Director, Product Development Laboratory, University of Pennsylvania

    Dr. Andrew Timmons; Biologist, Office of Tissues and Advanced Therapies, Division of Cellular & Gene Therapies, US Food and Drug Administration

    Dr. Boro Dropulić; Executive Director, Caring Cross

  • Contains 2 Component(s)

    The ASTCT webinar, 'Relapse after CAR T and mechanisms of relapse after CAR T,' aired on September 9, 2022 at 2 PM CDT.

    On Friday, September 9, 2022, ASTCT is hosting the second webinar in its 2022 CAR T Webinar Series. Join Drs. Eric Smith and Michael Jain as they review data and strategies to prevent relapse post CAR T, review current CAR T outcomes, and discuss possible published and proposed treatment strategies for CAR T relapse. Dr. Smith's presentation will focus on myeloma, and Dr. Jain's will focus on lymphoma. After their presentations, both speakers will answer questions from the audience. 

    Moderator:

    Dr. Mariana Lucena; Regional Medical Science Director, Medexus Pharma

    Faculty:

    Dr. Eric Smith; Director of Translational Research (Immune Effector Cell Therapies) at Dana-Farber Cancer Institute and Assistant Professor of Medicine, Harvard Medical School 

    Dr. Michael Jain; Assistant Member of the Department of Blood and Marrow Transplant and Cellular Immunotherapy at Moffitt Cancer Center


    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.

  • Contains 2 Component(s)

    The ASTCT webinar, 'Off the Shelf CAR T: a deep dive,' aired on Thursday, October 13, 2022, at 2 PM CDT.

    Join us for the third webinar in the ASTCT 2022 CAR T Webinar Series titled, 'Off the Shelf CAR T: a deep dive'. Drs. Matt Cooper and Swami Iyer will identify available off the shelf CAR T products, review the cell types used, and review the clinical, preclinical data, unique constructs and place in therapy of off the shelf CAR T products. Following their presentations, the session will move into a panel discussion facilitated by Dr. Laurie Davis. 


    Moderator:

    Dr. Laurie Davis; Assistant Professor of Pediatrics, Children's Hospital of San Antonio

    Faculty:

    Dr. Matt Cooper; Co-Founder & Chief Scientific Officer at WUGEN and Assistant Professor of Medicine at Washington University School of Medicine

    Dr. Swaminathan Iyer; Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center


    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.


  • Contains 2 Component(s)

    The ASTCT webinar, 'CAR T versus autologous Transplant (CAR T in a 2nd line setting) in lymphoma,' aired on Monday, October 17, 2022 at 12 PM CDT.

    On Monday, October 17, at 12 PM CDT, ASTCT hosted its fourth webinar in the 2022 ASTCT CAR T Webinar Series. Drs. Jeremy Abramson and Mazyar Shadman will review the three phase 3 trials (ZUMA-7, TRANSFORM, BELINDA) and discuss how the clinical trial data can be applied to actual non-study patients. After the review of the trials and the data, Drs. Abramson and Shadman will engage in a panel discussion.


    Moderator: 

    Dr. Antonio Vaz de Macedo; Head of the Hematology Clinic, Hospital da Polícia Militar, Brazil

    Speakers:

    Dr. Jeremy Abramson; Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center. Associate Professor of Medicine, Harvard Medical School

    Dr. Mazyar Shadman; Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center


    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.

  • Contains 2 Component(s)

    The ASTCT webinar, 'Practical perspective in using FDA approved CAR Ts, bridging therapy, and infection prophylaxis and vaccinations post CAR T,' aired on Tuesday, October 25 at 11 AM CDT.

    Join us for the fifth webinar in the 2022 ASTCT CAR T Webinar Series!

    On Tuesday, October 25, Drs. Joshua Hill, Joanna Yang, and Paolo Strati will give three talks focused on bridging therapy, infection prophylaxis and vaccinations, and prolonged cytopenia after CAR T. Following their presentations, the speakers will move into a Q&A facilitated by Dr. Tania Jain. 


    Moderator:

    Dr. Tania Jain; Director, Adult Chimeric Antigen Receptor T cell Therapy Program for Hematological Malignancies, Sidney Kimmel Comprehensive Cancer Center. Assistant Professor of Oncology, John Hopkins Medicine. 

    Speakers: 

    Dr. Joshua Hill; Assistant Professor Vaccine and Infectious Disease Division, Assistant Professor Clinical Research Division, Fred Hutchinson Cancer Research Center

    Dr. Joanna Yang; Assistant Professor of Radiation Oncology. Chief, Leukemia and Lymphoma Service. Director, Clinical Residency Program, Washington University School of Medicine in St. Louis

    Dr. Paolo Strati; Assistant Professor, The University of Texas MD Anderson Cancer Center 


    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.

  • Contains 2 Component(s)

    The ASTCT webinar, 'CAR T-Cells in Solid Tumors,' aired on Thursday, November 3 at 1 PM CDT.

    Join us on Thursday, November 3 at 1 PM CDT for the sixth and final webinar in the 2022 ASTCT CAR T Webinar Series! 

    In this webinar, Dr. Sneha Ramakrishna will review the current literature and clinical trial outcomes, discuss the unique challenges posed by the solid tumor microenvironment to adoptive cellular therapy, and discuss the upcoming modifications to CARs and combination therapies. Following Dr. Ramakrishna's talk, the webinar will move into an engaging panel discussion where Drs. Ramakrishna, Kaplan, and Park will answer questions from the audience. 

    Moderator:

    Dr. John Ligon; Assistant Professor in the Department of Pediatrics, University of Florida College of Medicine. 


    Speakers:

    Dr. Sneha Ramakrishna; Instructor of Pediatrics in the Division of Hematology and Oncology, Stanford Medicine. 

    Dr. Rosandra Kaplan; Senior Investigator, Pediatric Oncology Branch, National Institute of Health.  

    Dr. Julie Park; Professor of Pediatrics, UW School of Medicine; Associate, Clinical Research Division, Fred Hutchinson Cancer Research Center. Chief Medical Officer, Seattle Children's Therapeutics.


    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.